Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Chlormethine Gel Reshapes the Tumour Microenvironment in Mycosis Fungoides
9
Mins
March 2026
Cutaneous T cell lymphomas (CTCL) are a heterogenous group of rare malignancies primarily involving the skin, of which mycosis fungoides…
Read more
26 Jan 2016
Do the Guidelines in Oncology Need to Evolve?
Therapeutic guidelines in oncology, such as those from the National Comprehensive Cancer Network (NCCN) or the European Society for Medical Oncology…
26 Jan 2016
Diagnosis and Treatment of Bladder Cancer: From Established Paradigms to Recent Advances and New Perspectives
Bladder cancer (BC) certainly represents a challenging disease for the patient, given the significant impact on health-related quality of life, and for…
26 Jan 2016
Utility of Exosomes in the Diagnosis and Treatment of Pancreatic Adenocarcinoma
Pancreatic cancer is the most common lethal cancer, with annual incidence and mortality rates being approximately equal.
19 Nov 2015
The debate between prevention and cure of breast cancer by Prof. Rob Coleman
Prof. Rob Coleman gives an overview of the session “This house believes we should stop focussing on the causes of breast cancer and get on with…
12 Nov 2015
Intelligent Application of Breast Cancer Trials Data in the Clinic
This meeting commenced with a talk from Prof Loibl on neoadjuvant and adjuvant strategies for HER2positive (human epidermal growth factor receptor…)
12 Nov 2015
Incorporating PARP Inhibition in Cancer Therapy: Key Questions, Expert Answers
This engaging symposium focussed on the rationale and current evidence supporting the role for poly(adenosine diphosphate-ribose) polymerase (PARP)…
12 Nov 2015
Cabozantinib Versus Everolimus in Patients with Advanced Renal Cell Carcinoma: Results of a Randomised Phase III Trial (METEOR)
The METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma (RCC) was reported by Prof Choueiri at the European Cancer Congress…
12 Nov 2015
Current and Future Developments in the Treatment of CD30+ Lymphomas
CD30 is a cell membrane protein expressed on the surface of a range of lymphomas, which has important diagnostic, pathogenic, and prognostic roles.
Loading posts...
« Previous
1
…
24
25
26
27
28
…
31
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View